ABSTRACT
It has been suggested that dietary carotenoids can enhance immune function. Supplementation with beta-carotene (15 mg daily) was previously shown to enhance human monocyte function. To examine the effect of other dietary carotenoids, two similar independent studies were done. Healthy adult male nonsmokers were randomly assigned to receive lycopene (study 1), lutein (study 2), or placebo for 26 days, followed by the alternative treatment for another 26 days. The expression of functionally related monocyte surface molecules was quantified by laser flow cytometry before and after each treatment period. There was a significant increase in plasma levels of each carotenoid following dietary supplementation, but the effects on monocyte surface molecule expression were not as striking as those observed after beta-carotene supplementation. These findings emphasize that it cannot be assumed that the effect of one carotenoid will be the same as another, even at the same level of intake.
Subject(s)
Antigens, CD/blood , Antioxidants/pharmacology , Carotenoids/pharmacology , HLA-D Antigens/blood , Lutein/pharmacology , Monocytes/immunology , Adolescent , Adult , Carotenoids/administration & dosage , Carotenoids/blood , Cross-Over Studies , Dietary Supplements , Humans , Lutein/administration & dosage , Lycopene , Male , Middle Aged , Monocytes/drug effects , Placebos , beta Carotene/pharmacologySubject(s)
CD58 Antigens/biosynthesis , Carotenoids/pharmacology , HLA-DR Antigens/biosynthesis , Intercellular Adhesion Molecule-1/biosynthesis , Monocytes/immunology , beta Carotene/pharmacology , Adolescent , Adult , Anticarcinogenic Agents/pharmacology , CD58 Antigens/blood , Carotenoids/blood , Food, Fortified , HLA-DR Antigens/blood , Humans , Intercellular Adhesion Molecule-1/blood , Lycopene , Male , Middle Aged , Monocytes/drug effects , Random Allocation , beta Carotene/bloodABSTRACT
Although there is strong epidemiologic evidence that diets rich in carotenoids such as beta-carotene are associated with a reduced incidence of cancer, the cellular mechanisms underlying this phenomenon remain unknown. This article describes the effect of dietary beta-carotene supplementation on both the expression of functionally associated surface molecules on human monocytes and on the secretion of the cytokine tumor necrosis factor-alpha (TNF-alpha) by monocytes, all of which are involved in the initiation and regulation of immune responses involved in tumor surveillance. A double-blind, placebo-controlled, crossover study was undertaken in which 25 healthy, adult male nonsmokers were randomly assigned to receive beta-carotene (15 mg daily) or placebo for 26 days, followed by the alternative treatment for a further 26 days. The expression of functionally related monocyte surface molecules was quantified by flow cytometry, and ex vivo secretion of TNF-alpha was quantified by an enzyme-linked immunosorbent assay, before and after each treatment period. After dietary supplementation there were significant increases in plasma levels of beta-carotene and in the percentages of monocytes expressing the major histocompatibility complex class II molecule HLA-DR and the adhesion molecules intercellular adhesion molecule-1 and leukocyte function-associated antigen-3. In addition, the ex vivo TNF-alpha secretion by blood monocytes was significantly increased after supplementation. These findings suggest that moderate increases in the dietary intake of beta-carotene can enhance cell-mediated immune responses within a relatively short period of time, providing a potential mechanism for the anticarcinogenic properties attributed to beta-carotene.